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Objective. The present study describes 5 cases of large-cell 
neuroendocrine carcinoma (LCNEC) of the uterine cervix, 
evaluating their clinical features and pathological profiles. 
Methods. Clinical data were obtained from the patients' 
clinical files at the combined gynaecological-oncology urut 
of Joharmesburg Hospital and the University of the 
Wifwatersrand Medical School, Joharmesburg, South Africa. 
A histopathological diagnosis was obtained after biopsy 
material from all 5 patients was examined microscopically 
and subjected to immunohistochemical staining with 
MNF116 (pankeratin), synaptophysin and chromagranin A, 
all of which are neuroendocrine markers. Two patients 
received pelvic radiotherapy only. None of the 5 patients in 
this series received chemotherapy or underwent surgery. 
Results. All 5 patients were adult females, with an average 
age of 57.3 years. The majority were multiparous, with the 
most common presenting complaint being vaginal bleeding. 
Three of the 5 patients presented with advanced-stage 
cervical carcinoma, with evidence of metastases in 2 of 
them. Treatment responses and long-term survival in ocr 
series proved to be disappointing as 3 of the 5 patients died 
in less than 6 months. On histopathological examination, all 
5 tumours showed features of a high-grade poorly 
differentiated malignant neoplasm with ulceration and 
extensive tumour necrosis including trabecular and 
organoid growth patterns. All 5 neoplasms also showed 
strong immunoreactivity for MNF116, while their endocrine 
nature was confirmed by staining for synaptophysin in all 
cases. None of the tumours showed positive staining for 
chromagranin A 
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Conclusions. LCNECs are rare tumours and distinct from 
other neoplasms of the uterine cervix. The results of this' 
study reaffirm the biologically aggressive nature of this 
uncommon tumour and its very unfavourable prognosis. 
S Afr Med I 2001; 91: 525-528. 
' 
Carcinoma of the cervix is the most common cancer in women 
in the developing world.' In South Africa, it comprises 34% of 
all malignant tumours in black females, including a lifetime 
risk of 1 in 26/ and with more than 20 new cases diagnosed per 
100 000 of the total female population (cervical squamous cell 
carcinoma being the predominant type) ' Large-cell 
neuroendocrine carcinomas (LC ECs) of the uterine cervix are 
rare, unusual and highly aggressive tumours with Jess than SO 
cases reported worldwide_... They are distinct from other 
tumours of the uterine cervix and appear to be more common 
than is generally accepted, and may be misdiagnosed as poorly 
differentiated adenocarcinoma.' 
It is impor tant to recognise LCNECs of the cervix since their 
behaviour closely parallels that of their highly aggressive 
small-cell counterparts.'_.7 At present, LCNECs have a very 
poor prognosis and as is true for small-cell carcinoma, optimal 
therapy for LCNECs has yet to be determined.'-'·7 Following a 
consensus workshop convened in 1997, endocrine tumours of 
the uterine cervix are now classified into four categories, 
namely classic (typical) carcinoid, atypical carcinoid, LCNEC 
and small-cell carcinoma' As this classification is identical to 
that for endocrine tumours of the lung, this should lead to a 
be tter understanding of the biology, therapy and natural 
history of this family of tumours. To the best of our knowledge, 
this is the firs t time tha t this very rare tumour, namely LCNEC 
of the uterine cervix, is being reported on from South Africa. 
MATERIAL AND METHODS 
Clinical data 
Patients were selected .from those attending the combined 
gynaecological-oncology unit at the Johannesburg Hospital and 
then chosen on the basis of a histopathological diagnosis of 
LCNEC of the uterine cervix. 
Tumours were staged according to the International 
Federation of Gynaecologists and Obstetricians (FIGO) staging 
system for carcinoma of the uterine cervix.• Clinical d ata were 
obtained from the patients' in-hospital clinical files, notes from 
the radiotherapy department and follow-up n otes from the 
gynaecological oncology unit. Four of the 5 patients had a 
routine chest radiograph, ultrasound examination of the 
abdomen and pelvis, complete blood count, as well as urea and 
electrolyte assessment. One patient also had liver function tests 
performed. Four of the 5 patien ts were also tested for HIV 
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(after informed consent was obtained); a purely departmental 
protocol not practised or offered routinely throughout South 
Africa. 
Biopsy material 
Histological sections of the 5 formalin-fixed, paraffin-
embedded biopsy specimens of LCNEC were stained with 
hematoxylin and eosin, and reviewed using established 
morphological criteria.• 
lmmtunohjstochemistry 
Additional sections from each biopsy specimen were subjected 
to a panel of immunohistochemical stains, namely MNF116 
(pankeratin), synaptophysin and chromagranin A. The sources 
and dilutions of the respective markers are given in Table I. 
RESULTS 
Clinical observations 
Clinical details with presentation, treatment and outcome for 
ailS patients are summarised in Table II. 
All patients were adult females and ranged in age from 42 to 
75 years (mean age 57.3 years). One patient did not return for 
further evaluation and treatment, while another (case 5) 
refused treatment. Three patients were postmenopausal. 
Reproductive history was obtainable from 4 patients, all of 
whom were multiparous. The most common presenting 
complaint was vaginal bleeding. One premenopausal patient 
(case 2) also complained of postcoital bleeding. 
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A BC = avidin biotin complex; HRP = horseradish peroxidase. 
Table D. Clinical presentation of patients with cervical LCNEC 
Patient/ case 
number Age (yrs) Parity HIV 
1 75 5 egative 
2 51 5 egative 
3 42 A A 
4 65 6 Negative 
5 55 3 Negative 
NA = not available; DXT = radiation therapy; LFU =lost to follow-up. 
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Other complaints included lower abdominal pain, lower 
back pain, vaginal discharge and weight loss. The cachexia was 
especially marked in 2 patients (cases 1 and 4). Three patients 
presented with advanced stage disease, namely stage 3b and 
4b. The second patient had evidence of lung metastases on a 
chest radiograph, while the fourth had evidence of liver 
metastases on abdominal ultrasound examination and 
abnormal liver function tests. Two patients received pelvic 
radiation, while another died before any treatment plan was 
instituted for her. Patient 2 died 2 weeks after her diagnosis 
was confirmed, while patients 4 and 1 died within 1 and 3 
months respectively, despite pelvic radiotherapy. Patients in 
this series did not undergo any surgery; nor did they receive 
any chemotherapy. 
Light microscopy 
All 5 tumours showed features of a high-grade, poorly 
differentiated malignant epithelial neoplasm with ulceration 
and extensive tumour necrosis. The pattern of growth in case 1 
was predominantly organoid, while in case 3 the tumour 
appeared more trabecular and cord-like, with haphazard 
infiltration of the cervical stroma. Case 2 showed a combination 
of the growth patterns observed in cases 1 and 3. Case 4 was 
composed predominantly of large, solid basaloid neoplastic 
islands. Case 5 showed closely packed broad trabeculae as well 
as solid basaloid islands and narrow trabecular structures 
similar to those observed in case 3. Peripheral palisading by 
tumour cells was a conspicuous feature in areas vvith a more 
solid, organoid appearance. The individual neoplastic cells 
were relatively large, with ill-defined intercellular borders, 
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Fig. 1. High-power view of cervical large-cell neuroendocrine 
carcinoma (case 5). Note ill-defined cellular rosettes, and large 
pleomorphic h1mour cells showing brisk mitotic activity. 
pleomorphic round to oval nuclei with irregular nuclei 
contours, a vesicular to slightly stippled chromatin pattern, and 
prominent nucleoli (Fig. 1). Occasional ill-defined rosettes were 
discernible in cases 4 and 5. Apoptotic tumour cells were seen 
throughout, and there was brisk mitotic activity, with all 5 
neoplasms showing in excess of 10 mitoses per 10 high-power 
fields (HPF), including atypical mitotic figures (MFs). Case 1 
showed scattered tumour cells containing intracytoplasmic 
hyaline globules of varying size. Biopsy-related crush artefact 
was a conspicuous feature in case 3. Cases 1 and 3 showed 
microscopic foci of malignant squamous differentiation. All 
cases showed extensive ulceration of the surface epithelium. 
Smail areas of residual benign, non-dysplastic squamous 
mucosa were, however, seen in cases 1 and 2. An associated 
small-cell neuroendocrine carcinomatous component was not 
observed in any of the neoplasms. 
Cases 1, 3 and 4 also harboured microscopic basaloid tumour 
islands somewha t reminiscent of those encountered in adenoid 
basal carcinoma of the cervix. An unusual observation in case 3 
was the focal presence of small non-congophilic cylinders of 
hyaline, eosinophilic basement membrane-like material 
enveloped by the neoplastic epithelial cells. 
Immunohistochemistry 
AilS cases showed immunoreactivity for MNF116, with 
characteristic par~uclear dot-like accentuation of the staining 
pattern (Fig. 2). The neuroendocrine nature of the neoplasms 
was confirmed with diffuse staining for synaptophysin, which 
was moderate in cases 1 - 4, and strongly positive in case 5 
(Fig. 3). one of the 5 tumours showed positive staining for 
chromagranin A. 
DISCU SSION 
Tumours of the uterine cervix showing neuroendocrine 
differentiation are rare but distinctive neoplasrns_'.6.7-"·'0 It has 
Fig. 2. Cervical large-eel/ neuroendocrine carcinoma stained with 
pankeratin marker, MNF116. Note characteristic paranuclear dot-like 
accentuation of staining pattern. 
Fig. 3. Siron$ immunostaining for synaptophysin, confirming the 
neuroendocnne nature of the carcinomatous lesion, which also 
exhibits conspicuous trabecular morphology. 
been proposed that these neoplasm may arise from cells 
containing neuroendocrine granules that are demonstrable in 
20% of normal cervices.' Albores-Saavedra and a sociates 
reported the first case in 1972, namely a primary carcinoid of 
the uterine cervix.'-' However, cervical neuroendocrine 
carcinomas other than those of the small-cell type have 
received little attention and were not recognised as a specific 
entity in the World Health Organisation (WHO) clas ification, 
except for the category of 'carcinoid tumour '.' 
LCNECs of the uterine cervix are now a well-recognised 
specific entity' and are considered to be more common than is 
generally appreciated, even though fewer than 50 cases have 
been reported worldwide.'"' Cervical LCNECs have been 
reported in women aged 21 - 62 years (mean age 34 years).' The 
patients presented with an abnormal Pap smear or vaginal 
bleeding.' These neoplasms are biologically aggressive tumours 
that are frequently misdiagnosed,' and are associated with a 
poor prognosis and a high mortality rate.'·' Their clinical course 
parallels that of small-cell carcinoma with widespread 
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dissemination and distant metastasis occurring early on in the 
disease process.•_, Optimal treatment for LCNECs has not yet 
been determined and response of metastases to chemotherapy 
is disappointing.7 In a previously published report/ 20 of 31 
patients (65%) died of disease, typically within 3 years of 
diagnosis. In the same series, extra-abdominal metastases were 
frequently observed, involving lungs and occasionally the 
brain.7 In the present study, the mean age of the 5 patients was 
57.3 years. All 5 patients presented with vaginal bleeding as a 
common symptom. Three of the 5 patients presented with 
advanced stage cervical carcinoma, with metastases to the lung 
in case 2 and liver metastases in case 4. Patients 1, 2, 4 and 5 
were lllV-negative. Long-term survival and prognosis in our 
series of patients proved to be disappointing, despite 
radiotherapy in patients 1 and 4. One patient (case 5) refused 
treatment. 
Of the 4 newly categorised tumours of the uterine cervix, 
LCNEC is biologically and morphologically similar to small-
cell carcinoma and atypical carcinoid of the cervix.' The most 
easily applied and reproducible criterion for distinguishing 
LCNEC from atypical carcinoid is the mitotic rate, that is the 
number ofMFs per 10 HPFsY 
Characteristically, LCNECs show greater mitotic activity 
(> 10 MF/10 HPF) accompanied by a higher grade of nuclear 
atypism, typically more extensive necrosis and positive 
staining for neuroendocrine markers.•_, In the present series, 
light microscopy revealed extensive tumour necrosis in all 5 
cases, with tumours showing organoid, trabecular and/ or 
cord-like growth patterns and hence fulfilling the diagnostic 
criteria laid down by Albores-Saavedra and associates.' All 5 
tumours displayed large individual neoplastic cells with 
abundant cytoplasm, irregular vesicular nuclei and prominent 
nucleoli. In addition, the 5 neoplasms showed in excess of 10 
mitoses per 10 HPFs. The neuroendocrine nature of the 
neoplasms was confirmed by a positive immune reactivity for 
synaptophysin, although none of the 5 tumours in this series 
showed positive staining for chromagranin A, a phenomenon 
that has been reported on by other authors.•.7.n In addition to 
the above findings, microscopic foci of malignant squamous 
differentiation were present in cases 1 and 3. In a recent report 
it has been reaffirmed that all histological categories of 
endocrine tumours of the uterine cervix can be associated with 
squamous cell carcinoma or an adenocarcinoma.12 Currently 
there is no evidence to suggest that these foci influence the 
prognosis of LCNEC. It has been postulated that these mixed 
tumours may arise from divergent differentiation of neoplastic 
cells, or may represent separate primary tumours.12 Tone of the 
neoplasms in this series showed an associated small-cell 
neuroendocrine carcinomatous component, although other 
authors have mentioned this coexistence.5•13 
In conclusion, cervical LCNECs are distinctive, unusual and 
aggressive neoplasms that are frequently misdiagnosed and 
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have a very poor prognosis. Their recognition is important, as 
it will allow an evaluation of appropriate therapies that may 
improve their unfavourable outcome. Equally important is the 
use of uniform diagnostic terminology, as this will enable us to 
understand clearly their natural history and biological 
behaviour, and to estimate the incidence of this rare and 
virulent cervical cancer. 
The authors wish to thank Dr Peter King and Messrs Mike 
Lanesman and Guy Hall for the photomicrography, and Mr 
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